Biotech Values

[floblu14]

Momenta Pharmaceuticals Appoints Young T. Kwon as Vice President, Business Development

CAMBRIDGE, Mass., Jan. 4, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Young T. Kwon, Ph.D., has been appointed the Company's new Vice President of Business Development.

Craig A. Wheeler, CEO of Momenta, commented, "We are delighted to have Young join our team. His valuable industry experience will be critical to us as we evaluate collaboration opportunities and execute on our business development initiatives. Building on his strong background in biologic products, Young will also play a key strategic leadership role as we advance our follow-on biologics product portfolio."

Prior to joining Momenta, Dr. Kwon was Senior Director, Business Development, at Biogen Idec where he was responsible for leading corporate development activities, including evaluation of mergers and acquisitions, joint ventures and other strategic transactions. Prior to that, he identified and invested in early-stage life science companies at Advanced Technology Ventures. Dr. Kwon received his bachelor's degree in biology from the Massachusetts Institute of Technology and his Ph.D. in biological chemistry and molecular pharmacology from Harvard University. He has co-authored numerous peer-reviewed publications in the area of neurobiology.

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=541322